Total Payments
$13,867
2024 Payments
$2,234
Companies
25
Transactions
453
Medicare Patients
3,095
Medicare Billing
$786,970
Payment Breakdown by Category
Food & Beverage$13,667 (98.6%)
Consulting$150.00 (1.1%)
Education$50.40 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,667 | 450 | 98.6% |
| Consulting Fee | $150.00 | 1 | 1.1% |
| Education | $50.40 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $3,532 | 82 | $0 (2024) |
| ABBVIE INC. | $1,874 | 85 | $0 (2024) |
| Allergan, Inc. | $1,580 | 52 | $0 (2020) |
| Alkermes, Inc. | $1,535 | 48 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,445 | 54 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $993.37 | 11 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $603.12 | 27 | $0 (2024) |
| ITI, Inc. | $437.39 | 15 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $382.18 | 11 | $0 (2024) |
| Lundbeck LLC | $379.86 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,234 | 88 | Janssen Pharmaceuticals, Inc ($521.85) |
| 2023 | $3,022 | 117 | AbbVie Inc. ($828.98) |
| 2022 | $2,303 | 76 | Janssen Pharmaceuticals, Inc ($1,042) |
| 2021 | $1,736 | 60 | Janssen Pharmaceuticals, Inc ($823.02) |
| 2020 | $859.78 | 32 | Allergan, Inc. ($375.58) |
| 2019 | $1,900 | 48 | Allergan Inc. ($940.75) |
| 2018 | $932.25 | 17 | Sunovion Pharmaceuticals Inc. ($611.11) |
| 2017 | $880.79 | 15 | Sunovion Pharmaceuticals Inc. ($356.98) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $35.41 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $42.41 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CNS | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/23/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: CNS | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Neuroscience | ||||||
| 09/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.92 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $40.43 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 879 | 3,295 | $444,300 | $247,604 |
| 2022 | 5 | 890 | 2,753 | $396,130 | $208,583 |
| 2021 | 4 | 608 | 2,337 | $346,570 | $190,935 |
| 2020 | 7 | 718 | 2,184 | $319,120 | $139,847 |
Total Patients
3,095
Total Services
10,569
Medicare Billing
$786,970
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 297 | 1,760 | $211,200 | $124,140 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 733 | $109,950 | $76,524 | 69.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 286 | 783 | $117,450 | $43,808 | 37.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 19 | 19 | $5,700 | $3,133 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 267 | 1,214 | $145,680 | $84,592 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 737 | $110,550 | $72,149 | 65.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 208 | 442 | $66,300 | $25,778 | 38.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 145 | 344 | $68,800 | $23,362 | 34.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $4,800 | $2,702 | 56.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 220 | 1,050 | $126,000 | $73,927 | 58.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 186 | 672 | $100,770 | $71,950 | 71.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 163 | 550 | $110,000 | $41,341 | 37.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 39 | 65 | $9,800 | $3,718 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 197 | 618 | $92,700 | $49,457 | 53.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 209 | 874 | $104,880 | $46,068 | 43.9% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 156 | 449 | $89,800 | $32,450 | 36.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 81 | 147 | $14,720 | $4,325 | 29.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 41 | 60 | $9,000 | $3,523 | 39.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 19 | $3,720 | $2,126 | 57.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 17 | 17 | $4,300 | $1,898 | 44.1% |
About Dr. Stephan Simonian, M.D
Dr. Stephan Simonian, M.D is a Mental Health healthcare provider based in Glendale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104924208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephan Simonian, M.D has received a total of $13,867 in payments from pharmaceutical and medical device companies, with $2,234 received in 2024. These payments were reported across 453 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($13,667).
As a Medicare-enrolled provider, Simonian has provided services to 3,095 Medicare beneficiaries, totaling 10,569 services with total Medicare billing of $786,970. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Mental Health
- Location Glendale, CA
- Active Since 09/20/2006
- Last Updated 09/11/2025
- Taxonomy Code 101YM0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104924208
Products in Payments
- VRAYLAR (Drug) $3,204
- INVEGA SUSTENNA (Drug) $2,759
- HETLIOZ (Drug) $1,334
- LATUDA (Drug) $993.37
- ARISTADA (Drug) $944.26
- REXULTI (Drug) $789.52
- CAPLYTA (Drug) $482.25
- LYBALVI (Drug) $440.39
- INVEGA TRINZA (Drug) $375.53
- SPRAVATO (Drug) $366.38
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $216.19
- AUSTEDO (Drug) $191.95
- QUVIVIQ (Drug) $177.94
- LOREEV XR (Drug) $165.13
- BOTOX COSMETIC (Biological) $127.66
- NAMZARIC (Drug) $121.74
- Trintellix (Drug) $108.78
- UZEDY (Drug) $106.12
- ABILIFY MAINTENA (Drug) $103.05
- TRINTELLIX (Drug) $102.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Mental Health Doctors in Glendale
Mr. Michael Sweeney, Msw, MSW
Mental Health
Mental Health
Ms. Nancy Nation, Lcsw, LCSW
Mental Health
Mental Health
Mrs. Mary Schmidt, Ma Rn, MA RN
Mental Health
Mental Health
Dr. Lana Nassen, Lpc, LPC
Mental Health
Mental Health
Mrs. Jessica Whitaker, Msw, MSW
Mental Health
Mental Health
Mrs. Heather Sestili, Mscp, Ncc, Rpt, Lpc, MSCP, NCC, RPT, LPC
Mental Health
Mental Health